TDOC

SEC source: 0001179110-20-011597 · edgar.xml · derivative · entry 3

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,600

Underlying: Common Stock · 4,000 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

SEC source: 0001179110-20-011597 · edgar.xml · nonDerivative · entry 2

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,276

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020.

SEC source: 0001179110-20-011597 · edgar.xml · nonDerivative · entry 1

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,276

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-20-011598 · edgar.xml · nonDerivative · entry 1

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 612,318

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020.

F2 · price: Represents the weighted average price of transactions ranging from $192.10 to $198.66. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001179110-20-011459 · edgar.xml · nonDerivative · entry 1

Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,819

F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

SEC source: 0001179110-20-011462 · edgar.xml · derivative · entry 2

Bischoff Christopher · CIK 0001783106 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,428

Underlying: Common Stock · 713 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F3 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020.

F3 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020.

SEC source: 0001179110-20-011462 · edgar.xml · nonDerivative · entry 1

Bischoff Christopher · CIK 0001783106 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,693

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

SEC source: 0001179110-20-011461 · edgar.xml · derivative · entry 3

Daniel Karen L · CIK 0001346985 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,428

Underlying: Common Stock · 713 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F4 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020.

F4 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020.

SEC source: 0001179110-20-011461 · edgar.xml · derivative · entry 2

Daniel Karen L · CIK 0001346985 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,382

Underlying: Common Stock · 6,460 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F3 · derivative.exercise_date: The restricted stock units vest in four substantially equal installments each quarter beginning November 25, 2020.

F3 · derivative.expiration_date: The restricted stock units vest in four substantially equal installments each quarter beginning November 25, 2020.

SEC source: 0001179110-20-011461 · edgar.xml · nonDerivative · entry 1

Daniel Karen L · CIK 0001346985 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,105

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

SEC source: 0001179110-20-011460 · edgar.xml · derivative · entry 3

Fenwick Sandra L · CIK 0001302954 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,428

Underlying: Common Stock · 713 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F3 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020.

F3 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020.

SEC source: 0001179110-20-011460 · edgar.xml · derivative · entry 2

Fenwick Sandra L · CIK 0001302954 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,921

Underlying: Common Stock · 6,460 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F3 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020.

F3 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020.

SEC source: 0001179110-20-011460 · edgar.xml · nonDerivative · entry 1

Fenwick Sandra L · CIK 0001302954 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,535

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

SEC source: 0001179110-20-011269 · edgar.xml · derivative · entry 1

TULLMAN GLEN · CIK 0001213349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,308

Underlying: Common Stock · 1,308 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F2 · derivative.exercise_date: The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021.

F2 · derivative.expiration_date: The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021.

SEC source: 0001179110-20-011268 · edgar.xml · derivative · entry 1

Fenwick Sandra L · CIK 0001302954 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,308

Underlying: Common Stock · 1,308 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F2 · derivative.exercise_date: The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021.

F2 · derivative.expiration_date: The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021.

SEC source: 0001179110-20-011267 · edgar.xml · derivative · entry 1

Daniel Karen L · CIK 0001346985 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,308

Underlying: Common Stock · 1,308 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F2 · derivative.exercise_date: The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021.

F2 · derivative.expiration_date: The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021.

SEC source: 0001179110-20-011266 · edgar.xml · derivative · entry 1

Bischoff Christopher · CIK 0001783106 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,308

Underlying: Common Stock · 1,308 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F2 · derivative.exercise_date: The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021.

F2 · derivative.expiration_date: The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021.

SEC source: 0001179110-21-001504 · edgar.xml · nonDerivative · entry 3

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 587,188

SEC source: 0001179110-20-011032 · edgar.xml · derivative · entry 3

Trencher Daniel · CIK 0001830122 · SVP Corporate Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,414

Underlying: Common Stock · 3,000 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

SEC source: 0001179110-20-011032 · edgar.xml · nonDerivative · entry 2

Trencher Daniel · CIK 0001830122 · SVP Corporate Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,413

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020.

SEC source: 0001179110-20-011032 · edgar.xml · nonDerivative · entry 1

Trencher Daniel · CIK 0001830122 · SVP Corporate Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,413

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-20-010858 · edgar.xml · derivative · entry 3

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,556

Underlying: Common Stock · 1,389 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

SEC source: 0001179110-20-010858 · edgar.xml · nonDerivative · entry 2

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,015

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 3, 2020.

SEC source: 0001179110-20-010858 · edgar.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,404

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-20-010860 · edgar.xml · derivative · entry 3

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,600

Underlying: Common Stock · 2,000 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

SEC source: 0001179110-20-010860 · edgar.xml · nonDerivative · entry 2

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,276

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020.

SEC source: 0001179110-20-010860 · edgar.xml · nonDerivative · entry 1

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,276

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-20-010859 · edgar.xml · nonDerivative · entry 3

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 637,593

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020.

F3 · price: Represents the weighted average price of transactions ranging from $200.22 to $200.67. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001104659-20-121880 · a4.xml · derivative · entry 3

Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,456

Underlying: Common Stock · 34,456 shares

Expires 2028-06-18

F4 · derivative.exercise_price: Reflects options acquired by the Reporting Person on October 30, 2020, upon completion of the Merger pursuant to the Merger Agreement, based on the Reporting Person's previously outstanding options of Livongo, multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. Upon completion of the Merger, the exercise prices of the Reporting Person's options were adjusted based on the quotient of the exercise price of the Reporting Person's previously outstanding options of Livongo over an equity award adjustment ratio of 0.6891 (rounded up to the nearest whole cent), which was only determinable on November 3, 2020 in accordance with the Merger Agreement.

F4 · date: Reflects options acquired by the Reporting Person on October 30, 2020, upon completion of the Merger pursuant to the Merger Agreement, based on the Reporting Person's previously outstanding options of Livongo, multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. Upon completion of the Merger, the exercise prices of the Reporting Person's options were adjusted based on the quotient of the exercise price of the Reporting Person's previously outstanding options of Livongo over an equity award adjustment ratio of 0.6891 (rounded up to the nearest whole cent), which was only determinable on November 3, 2020 in accordance with the Merger Agreement.

F4 · price: Reflects options acquired by the Reporting Person on October 30, 2020, upon completion of the Merger pursuant to the Merger Agreement, based on the Reporting Person's previously outstanding options of Livongo, multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. Upon completion of the Merger, the exercise prices of the Reporting Person's options were adjusted based on the quotient of the exercise price of the Reporting Person's previously outstanding options of Livongo over an equity award adjustment ratio of 0.6891 (rounded up to the nearest whole cent), which was only determinable on November 3, 2020 in accordance with the Merger Agreement.

F6 · derivative.exercise_date: One-fourth of the option vested on June 19, 2019 and 1/48 of the option vests monthly thereafter.

SEC source: 0001104659-20-121880 · a4.xml · derivative · entry 2

Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,128

Underlying: Common Stock · 239,128 shares

Expires 2027-12-03

F4 · derivative.exercise_price: Reflects options acquired by the Reporting Person on October 30, 2020, upon completion of the Merger pursuant to the Merger Agreement, based on the Reporting Person's previously outstanding options of Livongo, multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. Upon completion of the Merger, the exercise prices of the Reporting Person's options were adjusted based on the quotient of the exercise price of the Reporting Person's previously outstanding options of Livongo over an equity award adjustment ratio of 0.6891 (rounded up to the nearest whole cent), which was only determinable on November 3, 2020 in accordance with the Merger Agreement.

F4 · date: Reflects options acquired by the Reporting Person on October 30, 2020, upon completion of the Merger pursuant to the Merger Agreement, based on the Reporting Person's previously outstanding options of Livongo, multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. Upon completion of the Merger, the exercise prices of the Reporting Person's options were adjusted based on the quotient of the exercise price of the Reporting Person's previously outstanding options of Livongo over an equity award adjustment ratio of 0.6891 (rounded up to the nearest whole cent), which was only determinable on November 3, 2020 in accordance with the Merger Agreement.

F4 · price: Reflects options acquired by the Reporting Person on October 30, 2020, upon completion of the Merger pursuant to the Merger Agreement, based on the Reporting Person's previously outstanding options of Livongo, multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement. Upon completion of the Merger, the exercise prices of the Reporting Person's options were adjusted based on the quotient of the exercise price of the Reporting Person's previously outstanding options of Livongo over an equity award adjustment ratio of 0.6891 (rounded up to the nearest whole cent), which was only determinable on November 3, 2020 in accordance with the Merger Agreement.

F5 · derivative.exercise_date: One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter.

SEC source: 0001104659-20-121880 · a4.xml · nonDerivative · entry 1

Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,743

F1 · date: Reflects shares of common stock, par value $0.001 per share, of the Issuer ("Common Stock") underlying restricted stock units ("RSUs") acquired by the Reporting Person on October 30, 2020, upon completion of the merger (the "Merger") of Tempranillo Merger Sub, Inc., a wholly owned subsidiary of the Issuer, with and into Livongo Health, Inc. ("Livongo") pursuant to the Agreement and Plan of Merger, dated as of August 5, 2020 (the "Merger Agreement"), based on the Reporting Person's previously outstanding RSUs of Livongo multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement.

F1 · shares: Reflects shares of common stock, par value $0.001 per share, of the Issuer ("Common Stock") underlying restricted stock units ("RSUs") acquired by the Reporting Person on October 30, 2020, upon completion of the merger (the "Merger") of Tempranillo Merger Sub, Inc., a wholly owned subsidiary of the Issuer, with and into Livongo Health, Inc. ("Livongo") pursuant to the Agreement and Plan of Merger, dated as of August 5, 2020 (the "Merger Agreement"), based on the Reporting Person's previously outstanding RSUs of Livongo multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement.

F2 · shares: The shares of Common Stock underlying the RSUs vest as follows: (1) 41,273 RSUs vest in 48 equal monthly installments beginning on January 15, 2019, although the vesting of these RSUs beginning in February 2020 was modified by Livongo such that the RSUs vest on the February 25, May 25, August 25 or November 25 that occurs immediately prior to applicable vesting date, and (ii) 23,688 and 13,746 RSUs vest in 16 equal quarterly installments beginning on August 25, 2019, and May 25, 2020, respectively.

F1 · price: Reflects shares of common stock, par value $0.001 per share, of the Issuer ("Common Stock") underlying restricted stock units ("RSUs") acquired by the Reporting Person on October 30, 2020, upon completion of the merger (the "Merger") of Tempranillo Merger Sub, Inc., a wholly owned subsidiary of the Issuer, with and into Livongo Health, Inc. ("Livongo") pursuant to the Agreement and Plan of Merger, dated as of August 5, 2020 (the "Merger Agreement"), based on the Reporting Person's previously outstanding RSUs of Livongo multiplied by an equity award adjustment ratio of 0.6891 (rounded down to the nearest whole share), which was only determinable on November 3, 2020 in accordance with the Merger Agreement.

F3 · balance_after: Includes shares of Livongo common stock acquired under the Livongo Health, Inc. 2019 Employee Stock Purchase Plan that were converted into 125 shares of Common Stock pursuant to the Merger Agreement.

SEC source: 0001179110-20-010832 · edgar.xml · derivative · entry 5

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,633

Underlying: Common Stock · 1,165 shares

Expires 2028-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.

SEC source: 0001179110-20-010832 · edgar.xml · derivative · entry 4

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,787

Underlying: Common Stock · 1,447 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

SEC source: 0001179110-20-010832 · edgar.xml · nonDerivative · entry 3

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020.

SEC source: 0001179110-20-010832 · edgar.xml · nonDerivative · entry 2

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,812

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-20-010832 · edgar.xml · nonDerivative · entry 1

Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,647

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-20-010859 · edgar.xml · derivative · entry 4

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 310 shares

Expires 2024-12-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter.

SEC source: 0001179110-20-010859 · edgar.xml · nonDerivative · entry 2

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 642,593

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020.

F2 · price: Represents the weighted average price of transactions ranging from $190.48 to $196.86. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001179110-20-010859 · edgar.xml · nonDerivative · entry 1

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 667,593

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-20-010804 · edgar.xml · derivative · entry 3

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,600

Underlying: Common Stock · 4,000 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

SEC source: 0001179110-20-010804 · edgar.xml · nonDerivative · entry 2

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,276

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020.

SEC source: 0001179110-20-010804 · edgar.xml · nonDerivative · entry 1

Verstraete Stephany · CIK 0001726419 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,276

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-20-120945 · a4.xml · nonDerivative · entry 1

Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,911

F1 · shares: Reflects shares of common stock, par value $0.001 per share, of the Issuer ("Common Stock") acquired by the Reporting Person on October 30, 2020, upon completion of the merger (the "Merger") of Tempranillo Merger Sub, Inc., a wholly owned subsidiary of the Issuer, with and into Livongo Health, Inc. pursuant to the Agreement and Plan of Merger, dated as of August 5, 2020 (the "Merger Agreement"). Pursuant to the Merger Agreement, upon completion of the Merger, each issued and outstanding share of Livongo common stock was converted into the right to receive 0.5920 shares of Common Stock and $4.24 in cash, without interest.

F1 · price: Reflects shares of common stock, par value $0.001 per share, of the Issuer ("Common Stock") acquired by the Reporting Person on October 30, 2020, upon completion of the merger (the "Merger") of Tempranillo Merger Sub, Inc., a wholly owned subsidiary of the Issuer, with and into Livongo Health, Inc. pursuant to the Agreement and Plan of Merger, dated as of August 5, 2020 (the "Merger Agreement"). Pursuant to the Merger Agreement, upon completion of the Merger, each issued and outstanding share of Livongo common stock was converted into the right to receive 0.5920 shares of Common Stock and $4.24 in cash, without interest.

SEC source: 0001179110-20-011315 · edgar.xml · derivative · entry 2

Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,181

Underlying: Common Stock · 3,181 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning October 30, 2021.

F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning October 30, 2021.

SEC source: 0001179110-20-011315 · edgar.xml · derivative · entry 1

Geshuri Arnnon · CIK 0001830520 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,365

Underlying: Common Stock · 7,365 shares

Expires 2030-10-30

F1 · derivative.exercise_date: The option vests as to 25% of the shares on October 30, 2021. The remainder of the shares vest in 36 equal monthly installments thereafter.

SEC source: 0001179110-20-010367 · edgar.xml · derivative · entry 3

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310

Underlying: Common Stock · 30,000 shares

Expires 2024-12-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter.

SEC source: 0001179110-20-010367 · edgar.xml · nonDerivative · entry 2

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 667,283

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020.

F2 · price: Represents the weighted average price of transactions ranging from $217.44 to $225.50. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001179110-20-010367 · edgar.xml · nonDerivative · entry 1

GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 697,283

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179110-20-010308 · edgar.xml · derivative · entry 6

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,945

Underlying: Common Stock · 1,389 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.

SEC source: 0001179110-20-010308 · edgar.xml · nonDerivative · entry 4

Turitz Andrew · CIK 0001726221 · SVP - Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,015

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 3, 2020.